A Study of SGN-B7H4V in Advanced Solid Tumors

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503389-22-00

Acronym

SGNB7H4V-001

Enrollment

147

Registered

2024-04-05

Start date

2022-08-31

Completion date

2025-01-13

Last updated

2024-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoid cystic carcinoma (ACC), Cholangiocarcinoma, Endometrial carcinoma, Fallopian tube cancer, Gallbladder carcinoma, HER2-negative, High-grade serous epithelial ovarian cancer, HR-positive breast cancer, Non-small cell lung cancer (squamous cell carcinoma [SqCC]), Primary peritoneal cancer, Triple-negative breast cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

France, Germany, Italy, Spain

Outcome results